Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Pharmaceuticals market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

4796 Item(s)

Page 1 of 480

  1. Global Cancer Monoclonal Antibodies Market 2017-2021

    By: Technavio
    , Published: Dec-2016
    , Product code: IRTNTR11278
    The report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded cancer mAbs and biosimilars used to treat cancer. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
    $3,500.00

  2. Global Multiple Myeloma Drugs Market 2017-2021

    By: Technavio
    , Published: Dec-2016
    , Product code: IRTNTR11277
    The report covers the present scenario and the growth prospects of the global multiple myeloma drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent multiple myeloma.
    $3,500.00

  3. Global First Aid Kit market 2017-2021

    By: Technavio
    , Published: Dec-2016
    , Product code: IRTNTR11248
    The report covers the present scenario and the growth prospects of the global first aid kit market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of first aid kits at the retailer level.
    $3,500.00

  4. Global Pompe Disease Treatment Market 2016-2020

    By: Technavio
    , Published: Dec-2016
    , Product code: IRTNTR11105
    The report covers the present scenario and the growth prospects of the global Pompe disease treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the drugs available in the market and the drug candidates that are in various phases of development for the treatment of Pompe disease.
    $2,500.00

  5. Spa Market in Europe 2016-2020

    By: Technavio
    , Published: Dec-2016
    , Product code: IRTNTR11087
    The report covers the present scenario and the growth prospects of the spa market in Europe for 2016-2020. To calculate the market size, the report considers the revenue generated from the spa services.
    $2,500.00

  6. Global Human Respiratory Syncytial Virus Drugs Market 2016-2020

    By: Technavio
    , Published: Dec-2016
    , Product code: IRTNTR11070
    The report covers the present scenario and the growth prospects of the global human respiratory syncytial virus drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent respiratory syncytial virus infections.
    $2,500.00

  7. Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

    By: GBI Research
    , Published: Dec-2016
    , Product code: GBIHC426MR
    Hypertension is a serious and common medical condition characterized by elevated blood pressure. It is commonly seen in the aging population, and in people with sedentary lifestyles and obesity. As one of the most significant preventable causes of death worldwide, early diagnosis of the condition is crucial to improve health outcomes. Hypertension is the key risk factor for stroke; according to the National Stroke Association (NSA), two-thirds of patients who suffer a stroke have hypertension.
    $4,995.00

  8. Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

    By: GBI Research
    , Published: Dec-2016
    , Product code: GBIHC417MR
    Type 2 diabetes mellitus (T2DM) is a chronic, progressive and serious metabolic disorder characterized by hyperglycemia (high blood glucose levels) and associated with numerous complications and co-morbidities, including cardiovascular, renal and neurodegenerative diseases.
    $6,995.00

  9. Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

    By: GBI Research
    , Published: Dec-2016
    , Product code: GBIHC427MR
    Hepatitis C is a blood-borne viral infection characterized by chronic inflammation of the liver. Although patients may be asymptomatic for a number of years or decades, chronic HCV infection can lead to liver fibrosis (formation of scar tissue) and ultimately liver cirrhosis, in which permanent fibrotic scar tissue replaces healthy liver cells. In severe cases, cirrhosis may lead to liver failure and death. In addition, hepatitis C patients are at an increased risk of developing liver cancer.
    $6,995.00

  10. EpiCast Report: Hepatitis C Virus - Epidemiology Forecast to 2025

    By: GlobalData
    , Published: Dec-2016
    , Product code: GDHCER135-16
    Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV). HCV can cause both acute and chronic hepatitis infection. According to the World Health Organization (WHO), an estimated 130-150 million individuals worldwide are affected with chronic HCV and about 500,000 people died of HCV-related conditions, including liver cirrhosis and hepatocellular carcinoma (HCC), in 2010 (Lozano et al., 2012; WHO, 2015).
    $3,995.00

4796 Item(s)

Page 1 of 480